Uniqure N.V.盘中异动早盘股价大跌5.00%报14.16美元

市场透视2025-05-30

北京时间2025年05月30日22时01分，Uniqure N.V.（QURE.us）股票出现波动，股价快速下跌5.00%。截至发稿，该股报14.16美元/股，成交量14.8585万股，换手率0.27%，振幅6.11%。最近的财报数据显示，该股实现营业收入1.57百万美元，净利润-43.64百万美元，每股收益-0.82美元，毛利-3.16百万美元，市盈率-3.23倍。机构评级方面，在所有14家参与...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2539273845?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-30 22:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2539273845","market":"us","top_or_hot":-1,"title":"Uniqure N.V.盘中异动 早盘股价大跌5.00%报14.16美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月30日22时01分，Uniqure N.V.（QURE.us）股票出现波动，股价快速下跌5.00%。截至发稿，该股报14.16美元/股，成交量14.8585万股，换手率0.27%，振幅6.11%。最近的财报数据显示，该股实现营业收入1.57百万美元，净利润-43.64百万美元，每股收益-0.82美元，毛利-3.16百万美元，市盈率-3.23倍。机构评级方面，在所有14家参与...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530220108950854e5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Uniqure N.V.盘中异动 早盘股价大跌5.00%报14.16美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUniqure N.V.盘中异动 早盘股价大跌5.00%报14.16美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-30 22:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530220108950854e5&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月30日22时01分，Uniqure N.V.（QURE.us）股票出现波动，股价快速下跌5.00%。截至发稿，该股报14.16美元/股，成交量14.8585万股，换手率0.27%，振幅6.11%。最近的财报数据显示，该股实现营业收入1.57百万美元，净利润-43.64百万美元，每股收益-0.82美元，毛利-3.16百万美元，市盈率-3.23倍。机构评级方面，在所有14家参与...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530220108950854e5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0820562030.AUD","symbol_name":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530220108950854e5&s=b","article_id":"2539273845","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530220108950854e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2539273845","pubTimestamp":1748613668,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月30日22时01分，Uniqure N.V.股票出现波动，股价快速下跌5.00%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为4.33%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。消息层面，截至22时01分，《神经科医生看好亨廷顿病将上市疗法 瑞银力挺uniQure潜力》资讯为影响Uniqure N.V.的重要信息。瑞银对 PTC Therapeutics Inc和 uniQure NV均持乐观态度，给予买入评级。该行强调，亨廷顿病领域患者认知度高、治疗意愿强烈，对PTC和uniQure而言均存在巨大机会。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","BK4581":"高盛持仓","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","BK4588":"碎股","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","LU2756315318.SGD":"ALLIANZ INCOME AND GROWTH \"AMG\" (SGDHDG) INC A","LU1496350171.SGD":"FRANKLIN DIVERSIFIED BALANCED \"A\" (SGDHDG) ACC","LU1035775433.USD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","LU1496350502.SGD":"FRANKLIN DIVERSIFIED DYNAMIC \"A\" (SGDHDG) ACC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU1674673691.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (USD) INC","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","BK4139":"生物科技","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4083":"家庭装潢零售","PTCT":"PTC Therapeutics Inc.","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU0942090050.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD)  INC","BK4566":"资本集团","LU2756315664.SGD":"ALLIANZ INCOME AND GROWTH \"AMI\" (SGDHDG) INC","LU0079474960.USD":"联博美国增长基金A","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","QURE":"uniQure N.V.","BK4585":"ETF&股票定投概念","BK4504":"桥水持仓","HD":"家得宝","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","BK4567":"ESG概念","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0868494708.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) INC","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","BK4550":"红杉资本持仓","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","LU1929549753.HKD":"FRANKLIN INCOME \"A\" (HKD) INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU0234572021.USD":"高盛美国核心股票组合Acc","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC"},"translate_title":"Uniqure N.V. 's intraday change plunged 5.00% to $14.16 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PTCT":1,"HD":1,"QURE":0.9},"content_text":"北京时间2025年05月30日22时01分，Uniqure N.V.（QURE.us）股票出现波动，股价快速下跌5.00%。截至发稿，该股报14.16美元/股，成交量14.8585万股，换手率0.27%，振幅6.11%。最近的财报数据显示，该股实现营业收入1.57百万美元，净利润-43.64百万美元，每股收益-0.82美元，毛利-3.16百万美元，市盈率-3.23倍。机构评级方面，在所有14家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为4.33%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 (To Pur Com)、Bioline Rx Ltd、Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)涨幅较大，Bioline Rx Ltd、Nucana Plc、Psyence Biomedical Ltd.较为活跃，换手率分别为437.94%、196.98%、104.50%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Abpro Holdings Inc C/Wts 12/11/2029 (To Pur Com)，振幅分别为49.50%、41.57%、39.72%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。 它为患有遗传性疾病和其他破坏性疾病的患者开发治疗方法和平台。 其产品和服务专注于血友病、亨廷顿病和心血管疾病。 该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。消息层面，截至22时01分，《神经科医生看好亨廷顿病将上市疗法 瑞银力挺uniQure潜力》资讯为影响Uniqure N.V.的重要信息。该信息摘要如下：瑞银近日发布生物科技领域研报，神经科医生对uniQure公司(QURE.US)的AMT-130(基因疗法)和PTC Therapeutics(PTCT.US)/诺华制药(NVS.US)公司的PTC-518(口服小分子)在亨廷顿病(HD)治疗中的表现十分乐观，若数据积极且疗法明日即可使用，则计划为25%的患者开具AMT-130处方，为40%的患者开具PTC-518处方。瑞银对 PTC Therapeutics Inc(PTCT)和 uniQure NV(QURE)均持乐观态度，给予买入评级。该行强调，亨廷顿病领域患者认知度高、治疗意愿强烈，对PTC和uniQure而言均存在巨大机会。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2539273845","isCrawlerRequest":true}

Uniqure N.V.盘中异动 早盘股价大跌5.00%报14.16美元

精彩评论

Uniqure N.V.盘中异动早盘股价大跌5.00%报14.16美元